Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 432Neoplasms 371Prostatic Neoplasms 205Lung Neoplasms 191Colorectal Neoplasms 153Motor Activity 94Uterine Cervical Neoplasms 81Pancreatic Neoplasms 78Head and Neck Neoplasms 75Carcinoma, Non-Small-Cell Lung 72Brain Neoplasms 71Ovarian Neoplasms 65Carcinoma, Hepatocellular 54Colonic Neoplasms 50Rectal Neoplasms 49Neoplasm Metastasis 48Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Glioblastoma 44Hematologic Neoplasms 41Depression 41Glioma 37Disease 37Melanoma 36Sarcoma 35Multiple Myeloma 35Stomach Neoplasms 34Carcinoma, Renal Cell 32Pain 31Urinary Bladder Neoplasms 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Fibroadenoma × 90 days × Clear all
NCT03044054 2026-05-01

HIFU-003

Theraclion

Phase NA Completed
113 enrolled

Fibroadenoma

NCT03868475 2026-03-09

VAPEX

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Withdrawn
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Cicatrix, Phyllodes Tumor, Patient Satisfaction, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡